STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

DARE DARE BIOSCIENCE INCORPORATED StockScouter® Report

3

StockScouter® Score

DARE BIOSCIENCE INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but is not suggestive of future returns. Neutral

 

Concerns

  • The 50-day moving average for DARE is below its 200-day moving average. Negative
  • Short-term relative price momentum exhibits moderate weakness. Neutral/Negative
  • The multi-period measure of relative price change and consistency is average. Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

C
N/A
N/A
C

Previous Ratings

1
1
4